<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="these outbreaks. In particular, otolaryngologists were at greater risk of" exact="infection" post="due to shedding of virus from nasal and pharyngeal"/>
 <result pre="of virus from nasal and pharyngeal mucosa.7 The implementation of" exact="infection" post="control methods, aggressive contact tracing and isolation limited the"/>
 <result pre="and pharyngeal mucosa.7 The implementation of infection control methods, aggressive" exact="contact tracing" post="and isolation limited the spread of disease in 2003"/>
 <result pre="pharyngeal mucosa.7 The implementation of infection control methods, aggressive contact" exact="tracing" post="and isolation limited the spread of disease in 2003"/>
 <result pre="The implementation of infection control methods, aggressive contact tracing and" exact="isolation" post="limited the spread of disease in 2003 and 2012."/>
 <result pre="high rates of asymptomatic carriers which promote the spread of" exact="infection" post="to susceptible populations,13 rather than greater stability of virus"/>
 <result pre="plays an important role in the first step of viral" exact="infection" post="by binding to the host ACE‐2 receptor, and initiating"/>
 <result pre="are highly conserved, since they are necessary to propagate the" exact="infection" post="in person to person spread. The amino acid sequence"/>
 <result pre="prolonged immunity. Neutralizing antibodies to SARS CoV‐1, that prevent viral" exact="infection" post="by preventing binding of the S protein to the"/>
 <result pre="that serve as markers of an immune response to CoV‐2" exact="infection" post="are necessary for the development of serologic testing and"/>
 <result pre="to CoV‐2 infection are necessary for the development of serologic" exact="testing" post="and vaccines. Currently numerous serologic tests using antibodies against"/>
 <result pre="April 8, 2020, 2020. 20ChengMP, PapenburgJ, DesjardinsM, et al. Diagnostic" exact="testing" post="for severe acute respiratory syndrome‐related coronavirus‐2:a narrative review. Ann"/>
 <result pre="2020;368:630‐633.32245784 23CoughlinMM, BabcookJ, PrabhakarBS. Human monoclonal antibodies to SARS‐coronavirus inhibit" exact="infection" post="by different mechanisms. Virology. 2009;394(1):39‐46.19748648 24LinJT, ZhangJS, SuN, et"/>
 <result pre="Engl J Med. 202010.1056/NEJMp2005630. 26TiradoSM, YoonKJ. Antibody‐dependent enhancement of virus" exact="infection" post="and disease. Viral Immunol. 2003;16(1):69‐86.12725690 27YasuiF, KaiC, KitabatakeM, et"/>
</results>
